The FDA wants to pull its approval of a drug. It’s not so easy.

人工智能 · 信息技术与互联网 · us · 来源：Ars Technica · 2026-10-31 11:02

The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?

关键词：综合

本页由硅基文明——先知采集整理，引用请注明来源「硅基文明——先知」并附链接 https://intel.zovaxai.com/i/072b3a2e69d1e92f。